Terms: = Cervical cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
3 results:
1. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (pd-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer.
Liu KH; Yang W; Tian HP
Clin Radiol; 2024 Feb; 79(2):e264-e272. PubMed ID: 37926648
[TBL] [Abstract] [Full Text] [Related]
2. Immunoscore system combining CD8 and pd-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer.
Chen H; Xia B; Zheng T; Lou G
Int J Biol Markers; 2020 Mar; 35(1):65-73. PubMed ID: 31808707
[TBL] [Abstract] [Full Text] [Related]
3. Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series.
Finger PT; Pavlick AC
J Immunother Cancer; 2019 Mar; 7(1):83. PubMed ID: 30909967
[TBL] [Abstract] [Full Text] [Related]
